ArticlePloS one2025
Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hepatitis B infection status & vaccine coverage among under five children in Mayurbhanj district, Eastern India.The Indian journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver past few years, global healthcare landscape has seen an increased recognition of the significance of infectious diseases, especially those affecting vulnerable populations such as young children, one of these diseases, Hepatitis B has emerged as a notable public health concern. Hepatitis B is highly transmissible during early years of life and may lead to complications like long-term chronicity, cirrhosis of liver and the progression of hepatocellular carcinoma. To address this growing concern, there is a pressing need for community-based studies to assess the prevalence, transmission patterns, risk factors, and potential interventions for Hepatitis B among children below the age of five. These studies should also assess the community's knowledge and practices regarding Hepatitis B and immunization.
methodsThe cross- sectional study will include a sample size of 2700 children aged between 1 to 5 years of Mayurbhanj district, Odisha. The serum samples will be tested for Hepatitis B surface antigen (HBsAg) and Hepatitis B surface antibody (anti-HBs). A detailed questionnaire will be prepared after focus group discussions with caregivers and healthcare workers to describe their knowledge and practices regarding HBV disease, associated risk factor and immunization. DISCUSSION: The prospective sero-epidemiological study conducted within the community will assist in determining the prevalence of Hepatitis B within the vulnerable population. It will provide valuable insights for monitoring the current status of Hepatitis B in Mayurbhanj district and contribute to enhancing ongoing efforts in vaccination, control, and eradication of Hepatitis B.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.